×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Worldwide schedules comment Share
3097 views

Modératrice :
Dr Olivia Le Saux

Au programme de cette soirée

18:00 Mécanismes d’action et biomarqueurs prédictifs de réponse
Dr Renaud Sabatier
 
18:20 Principales indications des inhibiteurs de PARP dans le cancer de l’ovaire et différences entre les inhibiteurs
Dr Jean-David Fumet
 
18:40 Prise en charge pratique des inhibiteurs de PARP : initiation, bilan minimal, suivi, toxicité
Dr Leila Bengrine-Lefevre
 
19:00 Résistance aux inhibiteurs de PARP et voies d’avenir (essais à venir)
Dr Olivia Le Saux
 
19:20 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2024-11-20
Last update : 2024-11-28

Suggestions

Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
Honolulu : Tuesday, March 22nd 2022 from 07am to 08:50am (GMT+1)
San Francisco : Tuesday, March 22nd 2022 from 09am to 10:50am (GMT+1)
New York : Tuesday, March 22nd 2022 from 12pm to 01:50pm (GMT+1)
Buenos Aires : Tuesday, March 22nd 2022 from 02pm to 03:50pm (GMT+1)
London / Dublin : Tuesday, March 22nd 2022 from 05pm to 06:50pm (GMT+1)
Paris / Berlin : Tuesday, March 22nd 2022 from 06pm to 07:50pm (GMT+1)
Istanbul : Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
Moscou / Dubaï : Tuesday, March 22nd 2022 from 09pm to 10:50pm (GMT+1)
Bangkok : Wednesday, March 23rd 2022 from 12am to 01:50am (GMT+1)
Shanghai : Wednesday, March 23rd 2022 from 01am to 02:50am (GMT+1)
Tokyo : Wednesday, March 23rd 2022 from 02am to 03:50am (GMT+1)
Sydney : Wednesday, March 23rd 2022 from 03am to 04:50am (GMT+1)
Wellington : Wednesday, March 23rd 2022 from 05am to 06:50am (GMT+1)

Cancer de l’ovaire

Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

Share
Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Share
Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, October 16th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Monday, October 16th 2023 from 09am to 10:30am (GMT+2)
New York : Monday, October 16th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Monday, October 16th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Monday, October 16th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
Sydney : Tuesday, October 17th 2023 from 03am to 04:30am (GMT+2)
Wellington : Tuesday, October 17th 2023 from 05am to 06:30am (GMT+2)

La nouvelle classification des cancers de l’endomètre en pratique

Cycle d'enseignement - Les cancers gynécologiques

Share
Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, March 14th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)

Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

Share
Scroll Up